Review: Antipsychotic augmentation is effective for people with obsessive-convulsive disorder who are receiving, but not responding to, serotonin reuptake inhibitor monotherapy - Commentary

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)24
Number of pages1
JournalEvidence-Based Mental Health
Issue number1
Publication statusPublished - Feb 2007

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this